Nonprofit Foundation Engages Industry On TB Diagnostics Development
This article was originally published in The Gray Sheet
Executive Summary
The Foundation for Innovative New Diagnostics is working with the diagnostics industry to create faster, more cost-effective tests for drug-resistant tuberculosis in developing countries
You may also be interested in...
New FDA Groups For Rare, Neglected Diseases Could Speed Path To Market
Two new FDA review groups to recommend solutions for the prevention, diagnosis and treatment of rare diseases and neglected diseases of the developing world would help get treatments to market faster, patient advocates and lawmakers say
New FDA Groups For Rare, Neglected Diseases Could Speed Path To Market
Two new FDA review groups to recommend solutions for the prevention, diagnosis and treatment of rare diseases and neglected diseases of the developing world would help get treatments to market faster, patient advocates and lawmakers say
Tests Designed For Developing World Could Benefit Established Markets, Too
Test makers should view the developing world as a primary market feeding new technologies into more established economies, rather than the other way around, said speakers July 28-29 at the American Association of Clinical Chemistry annual meeting in Washington, D.C